Back
Cadrenal Therapeutics Stock Price Chart
Trade Alert: Your First Two (Money Doubling?) Trades
Claim your first two trades here.
Sell
35
CVKD
Cadrenal Therapeutics
Last Price:
$11.71
Seasonality Move:
41.75%
7 Day Trial
ALL ACCESS PASS
$
7
Access Before Tuesday...
Grab your first two primed-to-double trades here.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVKD is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cadrenal Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.57 | Buy |
| 20-day SMA: | 10.93 | Sell |
| 50-day SMA: | 12.19 | Sell |
| 200-day SMA: | 15.38 | Sell |
| 8-day EMA: | 10.08 | Buy |
| 20-day EMA: | 7.11 | Buy |
| 50-day EMA: | 3.78 | Buy |
| 200-day EMA: | 1.1 | Buy |
Cadrenal Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 46.81 | Sell |
| Chaikin Money Flow: | 7772 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.36 - 12.22) | Sell |
| Bollinger Bands (100): | (11.63 - 16.71) | Sell |
Cadrenal Therapeutics Technical Analysis
| Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cadrenal Therapeutics Stock
Is Cadrenal Therapeutics Stock a Buy?
-
Cadrenal Therapeutics share price is 10.91 while CVKD 8-day simple moving average is 10.57, which is a Buy signal.
-
The stock price of CVKD is 10.91 while Cadrenal Therapeutics 20-day SMA is 10.93, which makes it a Sell.
-
Cadrenal Therapeutics 50-day simple moving average is 12.19 while CVKD share price is 10.91, making it a Sell technically.
-
CVKD stock price is 10.91 and Cadrenal Therapeutics 200-day simple moving average is 15.38, creating a Sell signal.
CVKD Technical Analysis vs Fundamental Analysis
Sell
35
Cadrenal Therapeutics (CVKD)
is a Sell
Is Cadrenal Therapeutics a Buy or a Sell?
-
Cadrenal Therapeutics stock is rated a SellThe current Cadrenal Therapeutics [CVKD] share price is $10.91. The Score for CVKD is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Cadrenal Therapeutics Stock Info
Market Cap:
22.3M
Price in USD:
10.91
Share Volume:
13K
Cadrenal Therapeutics 52-Week Range
52-Week High:
22.90
52-Week Low:
5.70
Sell
35
Cadrenal Therapeutics (CVKD)
is a Sell
Cadrenal Therapeutics Share Price Forecast
-
What is the Cadrenal Therapeutics stock price today?The Cadrenal Therapeutics stock price is 10.91 USD today.
-
Will CVKD stock go up or go down?Cadrenal Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cadrenal Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cadrenal Therapeutics is overvalued.
Is Cadrenal Therapeutics Stock a Buy?
-
Cadrenal Therapeutics share price is 10.91 while CVKD 8-day exponential moving average is 10.08, which is a Buy signal.
-
The stock price of CVKD is 10.91 while Cadrenal Therapeutics 20-day EMA is 7.11, which makes it a Buy.
-
Cadrenal Therapeutics 50-day exponential moving average is 3.78 while CVKD share price is 10.91, making it a Buy technically.
-
CVKD stock price is 10.91 and Cadrenal Therapeutics 200-day simple moving average is 1.10, creating a Buy signal.
Fundamental Analysis of Cadrenal Therapeutics
Is Cadrenal Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $2.54 per share.
Technical Analysis of Cadrenal Therapeutics
Should I short Cadrenal Therapeutics stock?
-
CVKD Moving Average Covergence Divergence (MACD) indicator is 2.92, suggesting Cadrenal Therapeutics is a Buy
-
Cadrenal Therapeutics Relative Strength Index (RSI) is 46.81, which suggest Cadrenal Therapeutics is oversold
-
The Bollinger Bands (25) for Cadrenal Therapeutics is (10.36 - 12.22), which suggest Cadrenal Therapeutics is a Sell
-
The Bollinger Bands (100) for Cadrenal Therapeutics is (11.63 - 16.71), which suggest Cadrenal Therapeutics is a Sell
* Cadrenal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.